Skip to content
Bored Studies
RecruitingPhase 1/Phase 2

BS01 in Patients With Retinitis Pigmentosa

Bionic Sight LLC · NCT04278131

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 1, Phase 2
Target enrollment
20
US sites recruiting
1
Study start
February 6, 2020
Record last updated
January 23, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

A Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP (AAV2-CAG-ChronosFP) in Patients with Retinitis Pigmentosa

Being studied: BS01

Conditions: Retinitis Pigmentosa

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Confirmed diagnosis of retinitis pigmentosa
  • At least one eye with vision no better than 20/160 visual acuity on the EDTRS scale or, for patients with peripheral vision loss, a visual field no greater than 30°.

Exclusion Criteria

  • Prior receipt of any AAV gene therapy product
  • Large amplitude nystagmus

Recruiting US locations

  • New Jersey Retina

    Teaneck, NJ 07666

    Site contact: Lauryn Onkendi · (201)837-7300 · lonkendi@njretina.com

Study contacts (from the official record)

  • Minako Koga · mkoga@kmphc.com
All phase 1 studies in New Jersey →
BS01 in Patients With Retinitis Pigmentosa (NCT04278131) | Bored Studies